Donepezil May Reduce Insulin-Like Growth Factor-1 (IGF-1) Levels in Alzheimer’s disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|15|1|108-112

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.1, 2016-02, pp. : 108-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting insulin-like growth factor-1 to treat Alzheimer's disease

By Torres-Aleman Ignacio  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1535-1542

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like Growth Factor-1 Receptor (IGF-1R) Kinase Inhibitors in Cancer Therapy: Advances and Perspectives

By  

Current Pharmaceutical Design, Vol. 18, Iss. 20, 2012-07 ,pp. : 2901-2913

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effect of Humanized Monoclonal Antibodies Targeting Insulin-Like Growth Factor 1 Receptor (IGF-1R) and Chemotherapy

By  

Current Drug Targets, Vol. 15, Iss. 7, 2014-06 ,pp. : 674-680

Bentham Science Publishers

Access to resources Recommend Favorite

Exogenous Insulin-Like Growth Factor (Igf)-1 Improves the Impaired Healing of Gastric Mucosal Lesions in Diabetic Rats

By Korolkiewicz R.P.   Tashima K.   Fujita A.   Kato S.   Takeuchi K.  

Pharmacological Research, Vol. 41, Iss. 2, 2000-02 ,pp. : 221-229

Academic Press

Access to resources Recommend Favorite

Recent Advancements in Small Molecule Inhibitors of Insulin–like Growth Factor-1 Receptor (IGF-1R) Tyrosine Kinase as Anticancer agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 653-681

Bentham Science Publishers

Access to resources Recommend Favorite